Detalhe da pesquisa
1.
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med;
177(4): 449-457, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38560901
2.
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Ann Intern Med;
2024 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38768457
3.
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Haematologica;
108(12): 3392-3398, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439374
4.
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being.
J Intern Med;
291(6): 837-848, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35112416
5.
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index.
Blood Cancer J;
13(1): 177, 2023 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38040702
6.
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
Blood Cancer J;
12(9): 133, 2022 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36100605
7.
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
Blood Cancer J;
11(12): 191, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34853309
8.
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Blood Cancer J;
11(5): 94, 2021 05 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34001889
9.
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Blood Cancer J;
13(1): 39, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36935437